The Continuous Glucose Monitoring Device (CGMD) Market size is projected to reach US$ 33.21 billion by 2031 from US$ 12.71 billion in 2024, registering a CAGR of 14.9% during 2025–2031. Continuous glucose monitoring devices provide near-real-time information on glucose levels through sensors designed for frequent or continuous measurements. Their ability to provide ongoing glucose insights is supporting the shift from periodic glucose testing toward more connected and data-driven diabetes management. Increasing diabetes prevalence, growing demand for convenient monitoring solutions, and advances in sensor and wearable technologies are contributing to market expansion.
What is driving the Continuous Glucose Monitoring Device (CGMD) Market?
The increasing prevalence of diabetes and growing demand for continuous, convenient glucose monitoring are major factors driving the Continuous Glucose Monitoring Device (CGMD) Market. Unlike traditional testing methods that provide glucose readings at individual points in time, CGMD systems can help users observe glucose patterns and changes throughout the day. This information can support patients and healthcare professionals in making more informed decisions regarding diabetes management.
Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPRE00018031
Technological advances are further increasing the appeal of CGMD systems. Improvements in sensor accuracy, wearability, connectivity, data visualization, and device miniaturization are making continuous monitoring more convenient for users. Integration with smartphones and digital health platforms also enables patients to review glucose trends and share relevant information with healthcare professionals.
The growing emphasis on proactive diabetes management is another important factor. Continuous data can help users identify changes associated with meals, physical activity, medication, and daily routines. As healthcare providers increasingly emphasize individualized diabetes care, CGMD technology is becoming an increasingly important component of connected disease-management strategies.
Which region leads the Continuous Glucose Monitoring Device (CGMD) Market?
North America represents a significant region in the Continuous Glucose Monitoring Device (CGMD) Market, supported by advanced healthcare infrastructure, high diabetes prevalence, strong adoption of digital health technologies, and the presence of leading device manufacturers. The US is an important market due to the availability of advanced diabetes-management technologies and increasing patient awareness of continuous monitoring.
Europe is also an important market, supported by established healthcare systems and increasing adoption of connected medical devices. Asia Pacific is expected to provide substantial growth opportunities as diabetes prevalence rises, healthcare infrastructure improves, and access to advanced glucose-monitoring technologies expands. Increasing awareness of diabetes management and growing availability of wearable health technologies can further support adoption across emerging markets.
Which segment leads the Continuous Glucose Monitoring Device (CGMD) Market?
Wearable sensor-based monitoring represents a major area of adoption within the Continuous Glucose Monitoring Device (CGMD) Market, as users increasingly seek convenient systems capable of collecting glucose information throughout daily activities. Sensor miniaturization and improvements in wearable design are helping make continuous monitoring more practical for long-term use.
The market also includes applications across different diabetes-management settings, ranging from individual home monitoring to clinical care. Integration with insulin delivery systems is an important area of development, as connected monitoring and therapy technologies can support more automated approaches to glucose management. Smartphone connectivity and cloud-based data platforms are further expanding the functionality of CGMD systems.
Which companies are prominent in the Continuous Glucose Monitoring Device (CGMD) Market?
Key companies profiled in the Continuous Glucose Monitoring Device (CGMD) Market include Abbott Laboratories, Medtronic Plc, F. Hoffmann-La Roche Ltd, Tandem Diabetes Care Inc., Ypsomed Holding AG, Dexcom Inc., i-SENS Inc., Senseonics Holdings Inc., A. Menarini Diagnostics s.r.l., and Medtrum Technologies Inc.
Competition in the market is influenced by sensor accuracy, wear duration, device size, connectivity, ease of use, data-management capabilities, and overall patient experience. Leading companies are investing in next-generation sensors, connected platforms, automated alerts, and integration with insulin delivery technologies. Product innovation is also focused on improving usability and making continuous monitoring accessible to broader patient populations.
What is changing in the Continuous Glucose Monitoring Device (CGMD) Market in 2026?
The Continuous Glucose Monitoring Device (CGMD) Market is increasingly shifting toward smaller, smarter, and more connected monitoring systems. Manufacturers are focusing on improving sensor performance while reducing device size and simplifying the user experience. Greater connectivity with smartphones, smartwatches, insulin pumps, and digital health platforms is also strengthening the role of CGMD technology within connected diabetes care.
Artificial intelligence and advanced data analytics are emerging as important areas of innovation. Large volumes of continuous glucose data can be analyzed to identify patterns and generate personalized insights. These capabilities may help users better understand glucose responses to food, exercise, medication, and other lifestyle factors while supporting healthcare professionals in monitoring long-term trends.
Another important development is the movement toward integrated diabetes-management ecosystems. CGMD systems are increasingly being designed to work alongside insulin delivery devices and other digital tools, potentially enabling more responsive and automated treatment approaches.
Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00018031
What are the major investment opportunities?
Investment opportunities in the Continuous Glucose Monitoring Device (CGMD) Market are expanding across sensor technologies, wearable devices, digital diabetes management, connected insulin delivery, and data-driven healthcare solutions. Companies developing smaller and more comfortable sensors with reliable performance can benefit from increasing demand for continuous monitoring.
Opportunities are also emerging in software and analytics platforms that transform continuous glucose data into actionable information. Integration with insulin pumps, mobile applications, telehealth platforms, and broader digital health ecosystems can create additional sources of value. Emerging markets represent another opportunity as diabetes care infrastructure expands and awareness of continuous monitoring increases. Companies that combine accurate sensing technology with connectivity, affordability, and user-friendly designs can strengthen their position in the rapidly evolving market.
Related Reports @
Glucose Monitoring Devices Market Size and Competitive Analysis by 2030
Blood Glucose Monitoring Devices Market Size, Share & Trends by 2034
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
Latest Post